ç³åãšã¢ã³ããšã€ãžã³ã°ã®é¢ä¿ãè žæŽ»ã©ããã¬ãžã³Vol.13ã
ã¯ããã«
ããã«ã¡ã¯ãããŸã ã§ããä»åã¯ãã¢ã³ããšã€ãžã³ã°ã«ãããŠèšåãããããšã®å€ããç³åãã«ã€ããŠè
žæŽ»ã©ããã¬ãžã³ã§åãäžããããšæããŸãã
åèã«ãªã£ãæ¹ã¯ãã²ã¹ããã¿ã³æŒããŠããã ãããšå¬ããã§ãïŒããã§ã¯ãããŸãããã
ããããç³åãšã¯ïŒ
ããããç³åãšèããšãã€ãã€ãè¿ãã€ã¡ãŒãžããªããããããŸããããå®ã¯éåžžã«èº«è¿ãªãã®ã§ããå ·äœçã«ã¯ããããã±ãŒããçŒããŠè²ãè€è²ã«å€åããããšããããç³åã§ããããã¯ãçä¹³ãåµã«å«ãŸããã¿ã³ãã¯è³ªãç ç³ãªã©ã®ç³ãå æž©ãããŠçµåããããšã«ããèµ·ãããŸãããã®åå¿ã¯ãã¡ã€ã©ãŒãåå¿ãšèšããŸãããããã¯ãã©ã³ã¹ã®ç§åŠè L.C.ã¡ã€ã©ãŒãã«ç±æ¥ããŸãã

ã¡ã€ã©ãŒãåå¿ã¯ãé£åå å·¥ã«ãããŠéåžžã«æŽ»èºããŠããŸããäžæ¹ã§ããããäœå
ã§èµ·ããŠããŸããšè²ã
ãªæªåœ±é¿ãåºãŠããŸããŸãã
ç³åãèµ·ããã®ã¯ãäœã®äžã§ç³åãéå°ã«ãªã£ãå Žåã§ãããã®ç³ãè¡äžãã现èã«åã蟌ãŸããã¿ã³ãã¯è³ªãšçµåãããšãè¶è²ããªãã ãã§ãªããäœã®çµç¹ãå
ãããããªããŸãããããŠãç³åã«ãããç³åæçµçæç©ïŒadvanced glycan endproducts AGEsïŒãã§ããŸããAGEsãšã¯ãæ§ã
ãªååç©ã®ç·ç§°ã§çäœå
ã§æ€åºããããã®ã ãã§ãNε-(ã«ã«ããã·ã¡ãã«)ãªãžã³ (CML) ããã©ãªã³ããã³ãã·ãžã³ãªã©40çš®é¡ä»¥äžãããŸãããã®AGEsã¯ãç³ã®éå°æåã ãã§ãªãã飲é
ãå«ç
ãè質ã®éå°æåã«å ãã玫å€ç·ãé
žåã¹ãã¬ã¹ãªã©ã«ãã£ãŠãçæããããããšãããã£ãŠããŸãã

ãã®AGEsãæ§ã
ãªçµç¹ãèåšã«èç©ãããšæ§ã
ãªçŸæ£ãèåã«ç¹ãããŸããäŸãã°ãèã§ããã°ãçç®ã®ã³ã©ãŒã²ã³ã«èç©ãããšãã³ã©ãŒã²ã³ç¹ç¶ã®éãã€ãªãæ¶æ©ãã§ããŠããŸããããã®ãããªæ§é ãåºå®ãããŠããŸããŸããããã«ãããã³ã©ãŒã²ã³ç¹ç¶ã®å¯åæ§ã倱ããã匟åãããªããªããªã£ãŠããŸããŸã(ref1)ãããã«ããã·ã¯ã«çºå±ããŸããããã«AGEsã¯ã骚匷床ã®äœäžã«é¢äžããŠããããšãå ±åãããŠããŸã(ref2)ã
ãŸããèèªäœã®ã¿ã³ãã¯è³ªãè¶è²ããªããšãé»è€å€ãçããŸããããã¯äœããšãããšãèã®ããã¿ã§ãã
ãããè¡ç®¡ã§èµ·ãããšã©ããªãã§ãããããæªçã³ã¬ã¹ãããŒã«ãšåŒã°ããLDL-Cã¯ãéåžžãã¯ããã¡ãŒãžãåè§£ããŸããããããLDL-Cãç³åããŠããŸããšããã¯ããã¡ãŒãžãåè§£ã§ããæ³¡æ²«çްèãšãããã®ã«ãªããè¡ç®¡å
ç®ã«èç©ãããããã¢ãããŒã ãšããå¡ãäœããåè硬åãåŒãèµ·ãããŠããŸããŸã(ref3)ã
ãŸããç³åã«ããçããAGEsãçµåããå容äœRAGE(receptor for AGEs)ãåãã¡ã®äœã®äžã«ã¯ååšããŸãããã®å容äœã«AGEsãçµåããããšã§ççãåŒãèµ·ããççæ§ãµã€ãã«ã€ã³ãçããçµç¹ãå
šäœçã«ççãèµ·ããããç¶æ
ã«ãªããŸãã

ç¥èªãAR: ã¢ã«ããŒã¹ã¬ãã¯ã¿ãŒãŒã SDH: ãœã«ãããŒã«ããããã²ããŒãŒã FK: ãã«ã¯ããããŒãŒã ALD B: ã¢ã«ãã©ãŒãŒ B; GAPDH: ã°ãªã»ã«ã¢ã«ããã-3-ãªã³é žããããã²ããŒãŒã ER: å°èäœã LSRDïŒçæŽ»ç¿æ £ç ã P-NH 2 : ã¿ã³ãã¯è³ªã®éé¢ã¢ããæ®åºhttps://dmsjournal.biomedcentral.com/articles/10.1186/s13098-020-00614-3
ãã以å€ã«ããã¢ã«ããã€ããŒåèªç¥çãªã©æ§ã
ãªçŸæ£ãšã®é¢ãããããããšãææãããŠããŸã(ref4)ã
ãã®ããã«ç³ååå¿ãäœã®äžã§èµ·ãããšæªåœ±é¿ãåãŒããŸããã§ã¯ãç³åãæžããã«ã¯ã©ã®ããã«ããã°ããã§ããããã
ç³åãäºé²ããé£ç掻
ç³åãé²ããŠããŸãã®ã¯ãé«è¡ç³ç¶æ ã§ãããšã¯ãããé«è¡ç³ã¯å¥åº·ãªäººã§ãæ®éã«é£äºããããšèµ·ããããç¶æ ã§ããé£äºã«ãã£ãŠè¡ç³å€ãé«ããªããšãããèã«ããã©ã³ã²ã«ãã³ã¹å³¶ã®Î²çްèããã€ã³ã¹ãªã³ãåæ³ããã现èã§ã®ç³ã®åã蟌ã¿ãä¿é²ãããè¡ç³å€ãäžãããŸããææŒæ©ãäžé£é£ã¹ãŠãã人ã§ããã°ãäžèšã®ãããªè¡ç³å€ã®å€åãèŠãããŸãã

äžæ¹ã§ãé£äºã®éãªã©ã«ãçãããã€ãªã©ãé£ã¹ãŠãããšãé«è¡ç³ã®ç¶æ
ãå¢ããŸããã€ãŸããç³åãé²ãæéãå¢ãããšããããšã§ãã
ãã®ãããæ®æ®µã®ç掻ã§ã§ããããšã¯ãé£åŸã®è¡ç³å€ã®äžæïŒæè¿ã§ã¯è¡ç³å€ã¹ãã€ã¯ãšãèšããŸãïŒãæ¥µåæžããããšã§ãã
ãŸããã§ããããšã¯ããããªãã飯ããã³ãªã©ã®çæ°Žåç©ãé£ã¹ãªãããšã§ããå
ã«éèãªã©ã®å¯èããé£ã¹ãããšã§ããããã«ãããè¡ç³å€ã®äžæãããããã«ãªããŸãããããã€ãšããã®æèã§èãããšãå¢ããããžãã¡ãŒã¹ããããã«ããããŸããããããæ¯åéèãé£ã¹ãã®ã¯é£ãããããããŸããããã®éã¯ãèãéãªã©ã¿ã³ãã¯è³ªããé£ã¹ãããšãããããããŠããŸãã
æ¥æ¬æçããã¬ã³ããªã©ã®ã³ãŒã¹æçã¯ããã®ç¹ãéèé¡ãã¡ã€ã³ã®èã»éãçæ°Žåç©ããã¶ãŒããšããé ã«ãªã£ãŠããç¹ã§è¡ç³å€ã®äžæãæããããããã«ã§ããŠãããªãšæããŸãã
ããããæ¥åžžçæŽ»ã§ã¯ããã®éãé£ã¹ãã®ã¯é£ããã§ããããå®é£ãªã©ãé£ã¹ãã«ããŠããã飯ãšãããã亀äºã«é£ã¹ãã®ãæ®éã ãšæããŸãã
ã§ã¯ããã®ããã«é£ã¹ãå Žåãè¡ç³å€ã¯ã©ããªãã®ã§ãããããäžèšã®ç ç©¶ãèŠãŠã¿ãŸããšã亀äºã«é£ã¹ãã«ããŠãããããïŒéèãªã©ïŒãšäžç·ã«é£ã¹ãã ãã§ãè¡ç³å€ã®äžæãããããã«ãªã£ãŠããããšãããããŸã(ref5)ã

æç³å飿ãé£ã¹ããïŒ
ãããŠãããã«ãããŸã§ã®ç ç©¶ã§ç³ååå¿ãæå¶ãã广ããããæç³å飿ããæããã«ãªã£ãŠããŸã(ref6)ãå ·äœçã«ã¯ãéèãããŒãããè¶ãªã©ã§ãã

æç³å飿ã®èœåã®æž¬å®æ¹æ³ã¯ãã·ã³ãã«ã§ããã¿ã³ãã¯è³ªãšç³ããŸãããšããã«ãæç³å飿ã®åè£ã®æœåºç©ããŸããŠãããŸãããŸãããšAGEsã®éãæžã£ãŠãããŸãããããŠãæœåºç©ããããããããŠãããšãAGEsã®éãå
ã®ååã«ãªãæ¿åºŠïŒIC50ïŒãããããŸãããã®æ¿åºŠãåè£ã®é£æããšã«æããã«ããŸãããã®å€ãå°ããã»ã©ãå°ãªãæ¿åºŠã§AGEsãé€å»ã§ãããã€ãŸããæç³åèœåãé«ããšããããšã§ãã
ãã®æç³åèœåã®ã©ã³ãã³ã°ã®äžäœãèŠãŠãããŸããšãéèã§ã¯ããµãã®ãšããã¢ããã€ã€ãããããããµããŒã¬ã¿ã¹ãªã©ãã©ã³ã¯ã€ã³ããŠããŸãããŸãããè¶ã§ã¯ãããŒãºããªãŒãçè¶ãã©ãã ã¿è¶ãäžäœã«ã©ã³ã¯ã€ã³ããŠããŸãã
ãããã®éèããè¶ãé£äºã«åãå
¥ããããšã§AGEsã®èç©ãäºé²ã§ããããšãæåŸ
ã§ããŸãã
ãŸããè¡ç³å€ãäžããèŠå ã«ãªã£ãŠããç³ãã²ããŠã¯çæ°Žåç©ã«ããããããªçš®é¡ããããè¡ç³å€ã®äžæããããã«ãéãããããŸãããã®æã«åèã«ãªãã®ãGIïŒã°ãªã»ããã¯ã»ã€ã³ããã¯ã¹ïŒã§ããããã¯ãè¡ç³å€ã®äžããããã瀺ããå€ã§ãé«ãã»ã©ãè¡ç³å€ããã°ããäžæããäœãã»ã©è¡ç³å€ãããããã«äžæããŸãã
è¡ç³å€ã®ä¹±ããæžããããã«ããäœGIã®é£åãåãå
¥ããŠãããŸã

https://ls-jp.fujifilm.com/karada-science-labo/article/what-is-glycemic-index-that-represents-the-rise-in-the-blood-sugar-leve/
ã±ãã³äœãšã®é¢ä¿
ãŸãã以åè žæŽ»ã©ããã¬ãžã³Vol.8ã§ã±ãã³äœã«ã€ããŠèšåããŸããããã±ãã³äœãåè§£ããŠã§ããã¢ã»ããŒã«ããAGEsã®äžã€Nε-(carboxyethyl)lysineïŒCELïŒãã§ããããšã確èªãããŠããŸãããããŠãç³å°¿ç ã®ã¢ãã«ã©ãããçšããç ç©¶ãããã¯ãšã³é žãçµå£ã§æäžãããšãã±ãã³äœã®çæïŒè æ©èœé害ãæå¶ãããã»ããçœå éããã³æ°Žæ¶äœã«ãããCELã®èç©ãææã«äœäžããããšãæããã«ãªããŸãã(ref7)ãã¯ãšã³é žã¯ãã¬ã¢ã³ãªã©ã®æç©ã«å ããç²åŽå埩ã®ããã«ãŒãªãŒã飲æãªã©ã«ããã䜿ãããŠããŸããããŸã䜿ãã°ãç³å°¿ç ã«ããå䜵çã ãã§ãªããå€ãã®çŸæ£ã®äºé²ãAGEsã®èç©å¯Ÿçã«ãªãããšãæåŸ ã§ããŸãã
è žå 现èå¢ãšã®é¢ä¿
ãŸããè
žå
现èå¢ãšã®ãããããç ç©¶ãããŠããããããŸã§ã«ç³ååå¿ã«ãã£ãŠã§ããçæç©ããæ§é å€åã§æ¶åã§ããªããããé£ç©ç¹ç¶ãšåæ§ã®åããããŠãããã£ãºã¹èãªã©ã®ãšãµã«ãªãããšãå ±åãããŠããŸã(ref8)ã
ããã¯äžèŠããããšã®ããã§ãããAGEså
šäœã®ãªã¹ã¯ãèæ
®ãããšããã®åããäžåãæªåœ±é¿ãåºãããšãæ³å®ãããŸãã®ã§é£ç©ç¹ç¶ã¯ãé£ç©ç¹ç¶ãšããŠå¥ã§æåããç³åä¿é²ããé£ã¹ç©ã¯æ¥µåé¿ããã«è¶ããããšã¯ãªããšèããŸãã
é£äºä»¥å€ã§ã§ããããš
é£äºä»¥å€ã§ç³åãæžããããã«ã§ããããšã¯äœãããã§ããããïŒ
ããã¯ãé£åŸã®éåã§ããéåã«ãããç³è³ªãæ¶è²»ãããè¡ç³ãé«ãç¶æ
ãè§£æ¶ãããŸãããããŸã§æ¿ããéåã§ãªããŠããæ£æ©ãããªã©è»œããã®ã§ã倧äžå€«ã§ãã®ã§ãéåãåãå
¥ããŠãããŸãããã
ãããã«
ããããå ã¯
ããã ãããµããŒãã¯ãè žæŽ»ã©ãã®éå¶ã調æ»ã®ããã«å€§åã«äœ¿ãããŠããã ããŸãã
